Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT), a global leader in analytical instrumentation and laboratory technologies, provides critical solutions for pharmaceutical development, food safety testing, and environmental monitoring. This dedicated news hub aggregates official announcements, financial disclosures, and strategic updates directly impacting the company's market position and technological advancements.
Investors and industry professionals will find curated updates including quarterly earnings reports, product innovation announcements, executive leadership changes, and regulatory developments. Our repository ensures timely access to filings, partnership agreements, and scientific breakthroughs related to Waters' chromatography systems, mass spectrometry platforms, and thermal analysis instruments.
Key content categories include financial performance updates, new product launches, research collaborations, and operational expansions. Bookmark this page to monitor developments affecting Waters' role in life sciences R&D, quality assurance protocols, and laboratory informatics solutions across 100+ countries.
Waters (NYSE:WAT) has announced its upcoming first quarter 2025 earnings conference call, scheduled for Tuesday, May 6th, 2025 at 8:00 a.m. Eastern Time. The presentation will be accessible through a live webcast on the company's Investor Relations website, with replay availability until June 3rd, 2025.
Waters is a global leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences. The company employs 7,600 people across 100+ countries, working with customers in laboratories, manufacturing sites, and hospitals to advance scientific benefits.
Waters (NYSE:WAT) has expanded its Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, enhancing capabilities for biopharmaceutical development and Quality Control laboratories. The system delivers significant improvements including:
- Up to 80x boost in sensitivity with MaxPeak™ Premier columns
- Over 3x improvement in day-to-day reproducibility
- Reduction in carryover by up to two orders of magnitude
- 40% reduction in common user errors
The platform is designed to simplify laboratory workflows and reduce out-of-specification results. All configurations are controlled by Waters Empower™ Chromatography Data System and support LIMS connectivity. The system has earned ACT Ecolabels from My Green Lab for sustainable manufacturing practices.
Waters (NYSE: WAT) has announced its participation in the upcoming Leerink Partners Global Healthcare Conference. CEO Udit Batra Ph.D. will engage in a fireside chat on Tuesday, March 11th, 2025 at 10:00AM Eastern Time.
The event will be accessible through a live webcast on Waters' Investor Relations website, with replay available for 90 days. Waters , with a 65-year legacy, operates globally as a leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences.
- Global presence in over 100 countries
- 7,600 employees worldwide
- Focus on medicine efficacy, food safety, water purity, and product quality
- Collaborates with laboratories, manufacturing sites, and hospitals
Waters (NYSE: WAT) reported strong Q4 2024 results with sales of $873 million, up 6% as reported and 8% in constant currency. Q4 highlights include 8% instrument growth and 9% recurring revenue growth in constant currency. Pharmaceutical sector showed robust performance, growing 10% in constant currency.
Full-year 2024 sales reached $2,958 million, flat year-over-year. The company achieved GAAP EPS of $10.71 and non-GAAP EPS of $11.86, up 1% from 2023 despite 5% foreign exchange headwinds. Waters generated strong cash flow with $762 million in operating cash flow and $744 million in free cash flow.
Looking ahead to 2025, Waters projects constant currency sales growth of 4.5% to 7.0%, with reported growth between 2.5% to 5.0% after accounting for currency impact. The company expects 2025 non-GAAP EPS between $12.70 and $13.00, facing approximately 4% headwind from foreign exchange.
Waters (NYSE:WAT) has launched the TA Instruments™ ElectroForce™ Apex 1 Mechanical Testing Instrument, designed for testing high-performance polymers and composites. The instrument offers 43% greater motor stroke range (100 mm) than competitors and can complete fatigue testing up to 30% faster, enhancing product development efficiency.
The system features automated controls and TuneIQ™ Technology for automatic instrument tuning without operator intervention. It includes improved break-stop capabilities and intelligent data acquisition to prevent computer overload. The instrument targets industries including medical device, polymer, aerospace, automotive, and additive manufacturing, where material strength and durability testing is crucial.
Waters (NYSE:WAT) has launched TGA Smart-Seal™ Pans from its TA Instruments Division, a new proprietary product for analyzing atmosphere-sensitive materials in benchtop thermogravimetric analyzers (TGA). The innovative self-opening sample container reduces TGA system costs and footprint by up to 50% by eliminating the need for environment-controlled housing or gloveboxes.
The Smart-Seal Pans feature a proprietary temperature-sensitive shape memory alloy that automatically opens at around 55°C, allowing air-sensitive materials to be prepared and sealed in an airtight environment. The technology enables analysis of materials used in battery development, advanced polymers, and medicines without exposure to ambient conditions.
The solution increases laboratory throughput while maintaining data quality, allows preparation of multiple samples simultaneously, and eliminates the need for costly gloveboxes that typically double TGA setup costs. The product is now available globally.
Waters (NYSE:WAT) has announced its upcoming fourth quarter 2024 financial results conference call, scheduled for Wednesday, February 12th, 2025 at 8:00 a.m. Eastern Time. The company will host a live webcast of the presentation through its Investor Relations website, with a replay available until March 12th, 2025.
Waters is a global leader in analytical instruments and software, specializing in chromatography, mass spectrometry, and thermal analysis innovations. The company employs approximately 7,500 people worldwide, operates in 35 countries with 15 manufacturing facilities, and distributes products in over 100 countries.
Waters (NYSE:WAT) has announced its upcoming Investor Day scheduled for March 5th, 2025, in New York City, beginning at 8:30 AM ET. The event will showcase presentations from senior management, highlighting business achievements, strategic priorities, and future value creation plans, followed by a Q&A session.
The company is offering both in-person attendance and live webcast options, with registration available through the Waters Investor Relations website. A replay of the webcast will be accessible after the event concludes.
Waters is a global leader in analytical instruments and software, known for innovations in chromatography, mass spectrometry, and thermal analysis. The company employs approximately 7,500 people worldwide, operates in 35 countries with 15 manufacturing facilities, and distributes products in over 100 countries.
Waters (NYSE: WAT) has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the fourth consecutive year, surpassing industry averages across all sustainability categories. The company achieved its greenhouse gas reduction target two years early in 2023 and made progress in STEM education advancement.
Waters has committed to setting science-based emission reduction targets aligned with the SBTi's criteria for a 1.5°C future. Notable achievements include building Massachusetts' first LEED-certified chemical manufacturing facility in 2022 and opening a 45,000 square foot BREEAM Very Good standard facility in the UK's West Midlands with an 'A' rated Energy Performance Certificate.
The DJSI recognition is based on the S&P Global Corporate Sustainability Assessment, which evaluates over 13,000 companies worldwide on industry-specific and financially material sustainability criteria.
Waters (NYSE:WAT) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Udit Batra Ph.D. will engage in a fireside chat on January 13th, 2025, at 2:15 PM Pacific Time. The event will be accessible via live webcast on Waters' Investor Relations website, with replay available for 90 days.
Waters is a global leader in analytical instruments and software, known for innovations in chromatography, mass spectrometry, and thermal analysis. The company serves life, materials, food, and environmental sciences sectors, employing approximately 7,500 people worldwide. Waters maintains direct operations in 35 countries, including 15 manufacturing facilities, with products available in over 100 countries.
